Pomalist
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Pomalist, covering 2017-04-12 to 2017-04-12. Get the full timeline:
Most recent: Clinical Trial Update: Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma [Phase 2]